Report On CME Group Inc.’s (CME) Price Performance


The stock of CME Group Inc. (NASDAQ:CME) increased by $2.42 on Wednesday to $176.67, up 1.39 percent. The last five days have seen an average of 1,833,558 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$52.00. The average number of shares traded over the last 20 days was 2,012,230, while the average volume over the last 50 days totaled 1,859,002.

CME stock appreciated 1.30% since last month. On 11/04/22, the company’s shares reached a one-month low of $169.22. The stock touched a high of $256.94 on 02/09/22, after rallying from a low of $166.58 in 52 weeks. The price of CME stock has declined by -23.73% or -$52.00 this year, reaching a new high 7 times. Still, the stock price is down -31.24% from the 52-week high.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Insider Transactions

CME stock investors should be aware that CME Group Inc. (CME) stock had its last reported insider trading activity 19 days ago on Nov 04. On Nov 04, Director SHEPARD WILLIAM R acquired 48,645 shares at $170.00 each. This transaction resulted in the insider spending $8,269,636. On Sep 20, McCourt Timothy Francis sold 97 shares at a price of US$189.29. After the transaction, the insider now owns 5,334 shares. Sr MD Global Head Equity & FX McCourt Timothy Francis had earlier sold 360 shares on Sep 19 for $190.77 a share. The transaction was completed for $68,677.

Valuation Metrics

CME Group Inc. (CME) has a trailing price-to-earnings (P/E) ratio of 23.77. Beta for the stock is 0.41. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 12.72, the price-to-book (PB) ratio of 2.21, and the price-to-cash flow ratio of 1180.82.

Company paid $1.00 per share in dividends, remained unchanged from $1.00 last year. A $2.25 dividend decrease was reported on Thursday February 3 2022.

Financial Health

For the three months ended September 29, CME Group Inc.’s quick ratio was 1.00, while its current ratio was 1.00, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending September 29 is 0.12, and the total debt to equity ratio is 0.12. CME Group Inc.’s operating margin stood at 61.20% for the same period. Based on annual data, it had gross profit of $2.04 billion and revenue of $4.69 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CME’s return on assets (ROA) during the last 12 months has been 1.40%. There was a 7.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 9.50%.

Earnings Surprise

According to CME Group Inc.’s quarterly financial report for the quarter that ended September 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.23 billion, while revenues rose by 9.6% to $1.24 billion. It was predicted that CME Group Inc.’s quarterly earnings would be $1.98, but it ended up being $1.94, beating the consensus by 2.10%. EBITDA was $828.8 million for the quarter. At the end of CME Group Inc.’s most recent quarter ended September 29, its liabilities totaled 150.18 billion, while its total debt was $3.95 billion. Equity owned by shareholders amounts to $359.73 million.

Technical Picture

Here’s a quick look at CME Group Inc.’s (CME) price momentum from a technical perspective. As of 22 November, the RSI 9-day stood at 58.59%, suggesting the stock is Neutral, with a 16.47% historical volatility rate.

The stochastic %K and %D were 69.18% and 58.99% respectively, while the average true range (ATR) was 3.61. Based on the 14-day stochastic reading of 76.86%, the RSI (14) reading is 54.15%. On the 9-day MACD Oscillator, the stock is at 1.28, and the 14-day reading is at 2.24.

Analyst Ratings

In its most recent analyst report, Deutsche Bank raised its rating on CME Group Inc. (NASDAQ: CME) to a Buy. Prior to this, analysts firm rated the stock as a Hold.


Please enter your comment!
Please enter your name here